Since the partial legalization of the medical, cosmetic and industrial use of cannabis in Morocco in 2021, a new era has opened for players in the sector, transforming a traditional product into a regulated sector. Among the emerging figures, Altaverda, which has become a pioneering cooperative, illustrates the successful transition between artisanal culture and industrialization in compliance with legal standards. This development marks a revolution in the exploitation of Moroccan cannabis, particularly the Beldia variety, with major implications for production, processing, distribution and export.
Altaverda was founded with the vision to design pharmaceutical solutions harnessing the power of cannabis. As a global leader, we are committed to bridging traditional knowledge and scientific innovation.
We integrate artisanal techniques with modern technologies to produce high-quality cannabis products, strictly adhering to GMP standards and international regulations.
Altaverda Pharmaceuticals adheres to evolving legalization frameworks worldwide, ensuring all products align with country-specific regulations, enhancing accessibility and adherence to the global legislative requirements.
Our compliance specialists ensure Altaverda meets all GMP and ISO standards, guaranteeing quality and safety across all our production stages, from cultivation to final distribution.
Partnered with regulatory bodies globally, Altaverda secures necessary approvals for entry into new markets, fostering trust and collaborative advancement within medical cannabis usage.
At Altaverda Pharmaceutical, we are dedicated to supervised agricultural production, industrial processing, and marketing & export while ensuring minimal environmental impact and adhering to strict global standards.
Supervising cultivation with advanced methods to maximize yield and quality.
Transforming raw materials into high-quality cannabis-derived products with precision.
Ensuring global distribution channels are optimized for a broader reach.